查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1291579

抗酸劑市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Antacids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

全球抗酸劑市場規模在2022年達到67億美元。展望未來，IMARC Group預計，到2028年，市場規模將達到86億美元，在2023-2028年期間呈現4%的成長率（CAGR）。

抗酸劑是非處方藥，可中和胃中的酸以緩解消化不良和胃灼熱。它們含有碳酸氫鈉、鋁、氫氧化鎂和鈣等成分，通常以方便的咀嚼片、粉末和液體形式提供。抗酸劑廣泛用於治療胃痛、消化不良的不適、胃潰瘍、炎症、消化不良和胃部不適。酸中和劑、促進劑和質子泵抑製劑是削弱胃酸的常見藥物。它們協助保護胃黏膜不受十二指腸、食道和進食時釋放的刺激性酸的影響。它們是自行開具的藥物，通過中和胃中的酸和抑制胃蛋白酶而發揮作用。

抗酸劑市場趨勢：

胃食道逆流病（GERD）的發病率越來越高，是推動市場成長的關鍵因素之一。抗酸劑被廣泛使用，因為它們具有成本效益，有助於緩解與胃灼熱有關的炎症、腫脹、疼痛和刺激。與此相應，生活方式的改變，如不規律的飲食習慣、睡眠模式和久坐的生活方式，對市場成長產生了積極的影響。此外，各種產品創新，如開發筏狀抗酸劑，是安全和強大的藥物，提供更高的療效和延長作用時間，正在為市場成長提供動力。此外，不同口味的咀嚼表的廣泛採用，易於儲存，提供正確的劑量，並提高病人的依從性，有利於市場成長。其他因素，如容易出現酸性併發症的老年人口的增加，通過電子商務平台容易獲得產品，以及大眾中胃灼熱現象的日益普遍，都為市場創造了積極的前景。

本報告中回答的關鍵問題：

  • 迄今為止，全球抗酸劑市場的表現如何，在未來幾年將如何表現？
  • COVID-19對全球抗酸劑市場的影響是什麼？
  • 主要的區域市場是什麼？
  • 基於藥物類別的市場細分是什麼？
  • 基於製劑類型的市場細分是什麼？
  • 基於配銷通路的市場細分是什麼？
  • 該行業價值鏈的各個階段是什麼？
  • 該行業的關鍵驅動因素和挑戰是什麼？
  • 全球抗酸劑市場的結構是什麼，誰是主要參與者？
  • 該行業的競爭程度如何？

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球抗酸劑市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按藥物類別分類的市場

  • 質子泵抑製劑
    • 市場趨勢
    • 市場預測
  • H2拮抗劑
    • 市場趨勢
    • 市場預測
  • 酸性中和劑
    • 市場趨勢
    • 市場預測
  • 促動劑
    • 市場趨勢
    • 市場預測

第7章：按配方類型分類的市場

  • 片劑
    • 市場趨勢
    • 市場預測
  • 液體
    • 市場趨勢
    • 市場預測
  • 粉末
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第8章：按配銷通路分類的市場

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 零售藥店
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第九章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十章：SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十一章：價值鏈分析

第十二章：波特斯五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十三章：價格分析

第十四章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • Abbott Laboratories
    • AstraZeneca plc
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Pfizer Inc.
    • Procter & Gamble Company
    • Reckitt Benckiser Group PLC
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
Product Code: SR112023A5082

The global antacids market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4% during 2023-2028.

Antacids are over-the-counter (OTC) medications that neutralize the acid in the stomach to relieve indigestion and heartburn. They contain ingredients such as sodium bicarbonate, aluminum, magnesium hydroxide, and calcium and are commonly available in convenient chewable tablets, powder, and liquid forms. Antacids are widely used for treating sore stomach, dyspepsia discomfort, stomach ulcers, inflammation, acid indigestion, and stomach upset. Acid neutralizers, promotility agents, and proton pump inhibitors are common drugs that weaken the acid in the stomach. They assist in protecting the stomach lining from the duodenum, esophagus, and harsh acids released while eating. They are self-prescribed medications and act by neutralizing the acid in the stomach and inhibiting pepsin.

Antacids Market Trends:

The increasing prevalence of gastroesophageal reflux diseases (GERD) is one of the key factors driving the growth of the market. Antacids are widely used as they are cost-effective and assist in relieving inflammation, swelling, pain, and irritation associated with heartburn. In line with this, changing lifestyles, such as irregular dietary habits, sleep patterns, and sedentary lifestyles, is positively impacting the market growth. Moreover, various product innovations, such as the development of raft-forming antacids that are safe and strong medications that provide higher efficacy and increased duration of action, are providing an impetus to the market growth. Additionally, the widespread adoption of chewable tables in different flavors that are easy to store, provide the correct amount of dosage, and improve patient adherence is favoring the market growth. Other factors, such as the rising geriatric population that are prone to acidic complications, easy product availability through e-commerce platforms, and the increasing prevalence of heartburn among the masses, are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global antacids market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class, formulation type and distribution channel.

Breakup by Drug Class:

Proton Pump Inhibitors

H2 Antagonist

Acid Neutralizers

Pro-Motility Agents

Breakup by Formulation Type:

Tablet

Liquid

Powder

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report:

  • How has the global antacids market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global antacids market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the formulation type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global antacids market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Antacids Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Drug Class

  • 6.1  Proton Pump Inhibitors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  H2 Antagonist
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Acid Neutralizers
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Pro-Motility Agents
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7   Market Breakup by Formulation Type

  • 7.1  Tablet
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Liquid
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Powder
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8   Market Breakup by Distribution Channel

  • 8.1  Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2  AstraZeneca plc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3  Bayer AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4  Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5  Dr. Reddy's Laboratories Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6  GlaxoSmithKline plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7  Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8  Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9  Procter & Gamble Company
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10  Reckitt Benckiser Group PLC
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11  Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12  Sun Pharmaceutical Industries Ltd.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13  Takeda Pharmaceutical Company Limited
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Antacids Market: Major Drivers and Challenges
  • Figure 2: Global: Antacids Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Antacids Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Antacids Market: Breakup by Drug Class (in %), 2022
  • Figure 5: Global: Antacids Market: Breakup by Formulation Type (in %), 2022
  • Figure 6: Global: Antacids Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Antacids Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Antacids (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Antacids (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Antacids (H2 Antagonist) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Antacids (H2 Antagonist) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Antacids (Acid Neutralizers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Antacids (Acid Neutralizers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Antacids (Pro-Motility Agents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Antacids (Pro-Motility Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Antacids (Tablet) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Antacids (Tablet) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Antacids (Liquid) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Antacids (Liquid) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Antacids (Powder) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Antacids (Powder) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Antacids (Other Formulation Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Antacids (Other Formulation Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Antacids (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Antacids (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Antacids (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Antacids (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Antacids (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Antacids (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Antacids Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Antacids Industry: SWOT Analysis
  • Figure 80: Global: Antacids Industry: Value Chain Analysis
  • Figure 81: Global: Antacids Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Antacids Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Antacids Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
  • Table 3: Global: Antacids Market Forecast: Breakup by Formulation Type (in Million US$), 2023-2028
  • Table 4: Global: Antacids Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Antacids Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Antacids Market: Competitive Structure
  • Table 7: Global: Antacids Market: Key Players